Guidance for market authorization requirements for COVID-19 drugs: Overview

Name: Guidance for market authorization requirements for COVID-19 drugs: Overview
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Guidance for market authorization requirements for COVID-19 drugs: Overview is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2022-07-28. On CanQuery you can follow the original downloads. Files are available in English and French.

This document provides guidance to drug manufacturers seeking authorization for their drug manufactured, sold, or represented for use in relation to COVID-19. The guidance explains recent changes to the regulatory process for new COVID-19 drugs.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2022-07-28

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Guidance for market authorization requirements for COVID-19 drugs: Overview (French, HTML) HTML · Download HTML
Guidance for market authorization requirements for COVID-19 drugs: Overview (English, HTML) HTML · Download HTML

Related open data

Health Canada